Download Free Medical Gestational Diabetes Mellitus Stake PowerPoint Presentation

Gestational Diabetes Mellitus Stake PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical PowerPoint presentation titled "Gestational Diabetes Mellitus – One Disease Two Lives at Stake" by Dr. VK Srivastava.

This medical PowerPoint presentation talks about gestational diabetes mellitus (GDM), a type of diabetes that develops during pregnancy. It is caused by insulin resistance, which means that the body does not respond to insulin properly, resulting in high blood sugar levels.

GDM usually develops in the second half of pregnancy and affects about 7% of all pregnancies. It is more common in women who are overweight or have a family history of diabetes.

The symptoms of GDM are often mild or nonexistent, but may include increased thirst and urination, blurred vision, fatigue, and frequent infections. It is usually diagnosed through a glucose tolerance test, which measures how well the body is able to process sugar.

Treatment for GDM usually involves making lifestyle changes such as eating a healthy diet, exercising regularly, and monitoring blood sugar levels. In some cases, medication or insulin may be necessary.

GDM can increase the risk of complications during pregnancy and delivery, including pre-eclampsia, preterm birth, and macrosomia (a large baby). Women with GDM are also at higher risk of developing type 2 diabetes later in life.

Therefore, it is important for women who have had GDM to have regular follow-up testing for diabetes and to adopt a healthy lifestyle to reduce their risk of developing type 2 diabetes in the future.

Tags : Gestational Diabetes Mellitus, pregnancy, endocrinology, endocrinology PowerPoint presentation

Published on : Apr 18, 2023 | Views : 1875 | Downloads : 6

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Gestational Diabetes Mellitus – One Disease Two Lives at Stake Dr. VK Srivastava MD, DPH, MSc Comm. Med. (London), FAMS, FIPSM, FIPHA, FSMS Secretary, International Epidemiological Association & Prof. & Head, Department of Community Medicine, Hind Institute of Medical Sciences, Lucknow Metro.
Slide 2-

Introduction Gestational Diabetes Mellitus (GDM) is defined as Impaired Glucose Tolerance (IGT) with onset or first recognition during pregnancy Worldwide, one in 10 pregnancies is associated with diabetes, 90% of which are GDM Undiagnosed or inadequately treated GDM can lead to significant maternal & foetal complications Women with GDM and their offsprings are at increased risk of developing Type 2 diabetes later in life
Slide 3-

The Problem In India, prevalence of GDM is appox.10-14.3% - much higher than the west As of 2010, India has:- 22 mill. women with diabetes in the age group of 20-39 with an additional 54 mill. women in this age group with impaired glucose tolerance (IGT) In view of high prevalence of GDM in Indian women, Govt. of India has released National Guidelines for Diagnosis & Management of Gestational Diabetes Mellitus in Dec 2014.
Slide 4-

Patho-physiology GDM is characterised by hyper-insulinaemia and insulin resistance In first trimester and early second trimester, increased insulin –due to high levels of oestrogen In late second and early third trimesters, insulin resistance - due to a number of antagonistic hormones especially, placental lactogen, leptin, progesterone, prolactin, cortisol and adiponection
Slide 5-

ppt slide no 5 content not found
Slide 6-

Implications of Diabetes in Pregnancy The risk of serious injury at birth - Doubles The likelihood of Caesarean delivery - Triples The incidence of Neonatal Intensive Care Unit admission - Quadruples
Slide 7-

Pregnancy and Diabetes- The vicious cycle Pregnancy Diabetes Mellitus
Slide 8-

Effects of Pregnancy on Diabetes During pregnancy, there is altered carbohydrate metabolism and impaired insulin action Insulin requirement increases as pregnancy advances Accelerated starvation----rapid activation of lipolysis with short period of fasting Higher risks of Ketoacidosis complications Accelerates vascular changes
Slide 9-

Effect of Diabetes on Pregnancy:1. Respiratory Distress Syndrome2. Polydydramnios3. Foetal macrosomia4. Erb’s Palsy5. Birth asphyxia6. Abortion/Intra uterine death 7. Neonatal hyperbilirubinemia 8. Congenital malformations
Slide 10-

Maternal Hyperglycaemia Foetal hyperglycaemia Foetal osmotic diuresis Polyhydramnios Polyhydramnios Fetal macrosomia Foetal hyperinsulinaemia Foetal hypoglycaemia Increased IGF Obstructed labour Shoulder Dystocia Erb's Palsy/ Birth Asphyxia Decreased cortisol production Respiratory distress syndrome Decreased surfactant synthesis in lung
Slide 11-

ppt slide no 11 content not found
Slide 12-

GDM: Risk Factors Age >25years BMI >25kg/m² Increased weight gain during pregnancy Previous history of large for gestational age infants History of GDM during previous pregnancies previous stillbirth with pancreatic islet hyperplasia on autopsy Ethnic group ( East Asian, Pacific Island ancestry) Elevated fasting or random blood glucose levels during pregnancy Family history of diabetes in first degree relatives History of metabolic X syndrome History of type I or type II Diabetes Mellitus Unexplained fetal loss
Slide 13-

GDM: Maternal Complications During Pregnancy Abortion Preterm labour (due to infection or polyhydramnios) Pre-eclampsia Polyhydramnios Maternal distress due to oversized fetus and polydramnios Microangiopathy- Nephropathy, retinopathy, neuropathy Large vessel disease Coronary artery disease Thromboembolic disease Infection Hypo and hyperglycaemia During labour Prolonged labour Shoulder dystocia Perineal injuries PPH Operative interference Increased risk of Caesarean delivery Puerperium Puerperal sepsis Lactational failure
Slide 14-

GDM: Foetal Complications 1st Trimester Congenital abnormalities Cardiac : ASD, VSD NTD Sacral agenesis/ CRS PCKD Renal agenesis Duodenal atresia Tracheo-esophageal fistula 2nd Trimester Macrosomia During delivery Birth asphyxia Shoulder dystocia After delivery RDS Hypoglycaemia Polycythaemia neonatal jaundice
Slide 15-

ppt slide no 15 content not found
Slide 16-

The White classification, named after Priscilla White on the effect of diabetes types on perinatal outcome. It distinguishes between gestational diabetes (type A) and diabetes that existed before pregnancy (pre-gestational diabetes). There are 2 classes of gestational diabetes (diabetes which began during pregnancy): Class A1: gestational diabetes; diet controlled Class A2: gestational diabetes; medication controlled The second group of diabetes which existed before pregnancy can be split up into these classes: Class B: onset at age 20 or older or with duration of less than 10 years Class C: onset at age 10-19 or duration of 10–19 years Class D: onset before age 10 or duration greater than 20 years Class E: overt diabetes mellitus with calcified pelvic vessels Class F: diabetic nephropathy Class R: proliferative retinopathy Class RF: retinopathy and nephropathy Class H: ischemic heart disease Class T: prior kidney transplant
Slide 17-

Signs Elevated serum glucose Glycosuria is of uncertain significance Ketonuria Elevated glycosylated haemoglobin Greater than normal abdominal circumference GDM: Diagnosis Symptoms Asymtomatic Insidious onset Polyuria, polyuria, polyphagia Fatigue and weight loss Women with established diabetes may have retinopathy or neuropathy
Slide 18-

Principles of Management (National Guidelines for Diagnosis and Management of GDM-2014)
Slide 19-

Who should be tested : The first testing - first antenatal contact as early as possible The second testing -24-28 weeks of pregnancy if the first test is negative At least 4 weeks gap between the two tests All Pregnant Women to be tested even if they come late in pregnancy If presents beyond 28 weeks of pregnancy-only one test to be done
Slide 20-

How to Test: Single step testing - 75 gm oral glucose & measure plasma glucose 2 hour after ingestion 75 gm glucose mixed with 300 ml water ingested whether the PW comes in fasting or non-fasting state A plasma standardised glucometer should be used to evaluate blood glucose 2 hours after the oral glucose load The threshold plasma glucose level of ≥140 mg/dl is taken as cut off for diagnosis of GDM.
Slide 21-

ppt slide no 21 content not found
Slide 22-

ppt slide no 22 content not found
Slide 23-

Antenatal care: All diabetic women are managed in a multidisciplinary combined obstetric and diabetic clinic with specialist obstetrician, diabetologist, specialist midwife, paediatrician and dietician All women should receive dietary instruction, with individual recommendations based on weight and height Patient should receive nutrition counselling from a registered dietician Daily calories should be made up approximately 40% carbohydrate, 20% proteins and 40% fats. This should improve blood glucose levels
Slide 24-

Medical Nutritional Therapy: Recommended diet should provide 1800 Kcal/ day 50%-60% -carbohydrate 10-20% - Proteins 25-30% - Fat
Slide 25-

ppt slide no 25 content not found
Slide 26-

Role of Ultrasound: Preferably done in first trimester to confirm gestational age by dates Repeated at 18 to 20 weeks gestation to evaluate the foetus for congenital anomalies Particularly important in patients with pre-existing type 1 and 2 diabetes and elevated first trimester HbA1c (>6.5%) Should be done at 30 to 32 weeks and 36-38 weeks of gestation to evaluate foetal size, amniotic fluid index, and to help ascertain the mode of delivery
Slide 27-

Tests of Foetal wellbeing Daily foetal movement counting: 32 weeks gestation and continue until delivery. Amniotic fluid index and biophysical profile. These tests are usually conducted twice weekly and are instituted at 32 to 34 weeks of gestation in women on insulin and can be done from 34-36 weeks of gestation in women whose diabetes is controlled by diet. Some clinicians manage patients with dietary control without any additional testing.
Slide 28-

Sulfonylureas Insulin secretagogues Glipizide, glyburide Increase insulin secretion, decrease hepatic glucose production with resultant reversal or hyperglycaemia and indirect improvement of insulin sensitivity Meglitinides Biguanides Decrease insulin resistance Alpha glucosidase inhibitors eg acarbose) Decrease intestinal absorption of starch and glucose Thiazolidinediones Eg rosiglitazone and pioglitazone ORAL HYPOGLYCAEMIC AGENTS Not Recommended in National Guidelines - only Insulin to be used
Slide 29-

Time and Mode of Delivery All pregnant women advised during the antenatal care about the potential risks of pregnancy progressing beyond term Gestational diabetes GDM on diet with no complications can be delivered at 40 weeks GDM on insulin should be delivered by induction of labour at 38-39 weeks Pre-existing diabetes Diabetes itself not an indication for Caesarean Section Pregnant women with diabetes who have a normally grown fetus should be offered elective birth through induction of labour, or by elective caesarean if indicated, after 38 completed weeks Pregnant women with ultrasound features of macrosomic fetus (fetal weight more than 4.5kg) and poorly controlled blood sugar are delivered by elective caesarean section.
Slide 30-

Post-delivery Follow up of GDM Cases Women with GDM are at higher risk for Type 2 Diabetes mellitus. Maternal glucose levels usually return to normal after delivery. GDM cases are not discharged after 48 hours unlike others, FPG & 2 hr PPPG is performed on the 3rd day of delivery Subsequently, ANM to perform 75 g GTT at 6 weeks postpartum Cut offs for normal blood glucose values are: Fasting plasma glucose: ≥ 126 mg/dl 75 g OGTT 2 hour plasma glucose Normal: < 140 mg/dl IGT: 140-199mg/dl Diabetes: ≥ 200 mg/dl
Slide 31-

Operational Aspects of National GDM Guidelines
Slide 32-

Role of Health Personnel at different levels of Health Facility: Village Level ASHA: To mobilise & counsel PW for timely testing & follow up Sub-centre Level ANM: Testing/MNT/Referral of cases needing medical management Maintaining records, monitoring & follow up
Slide 33-

Role of Health Personnel at different levels of Health Facility...contd. PHC/ UPHC Level GDM controlled on MNT can be delivered by ANM/SN GDM on Medical management with Insulin therapy- by MOs GDM not controlled by Insulin therapy/GDM with complications should –to referred to higher facility for care by a specialist Maintaining records, monitoring & follow up
Slide 34-

Role of Health Personnel at different levels of Health Facility ..contd. DH & All CEmOC centres All jobs as defined under PHC level + Specialist/Gynaecologist/MO: Management of all types of GDM cases MC & other Super-speciality centres Comprehensive management of GDM including all referral cases
Slide 35-

Capacity building of Health personnel under GDM Guidelines
Slide 36-

Training needs for different cadres
Slide 37-

Training needs for different cadres
Slide 38-

Training needs for different cadres
Slide 39-

Screening for GDM Most patients with GDM have normal fasting glucose levels. The challenge of glucose tolerance must be done for most cases with GDM.
Slide 40-

Screening –at the 24 weeks visit OGTT should be done. There are some controversies. whether the universal or selective OGTT should be done? Which blood glucose level should be the optimal cutoff for diagnosis?
Slide 41-

Screening Strategy Every pregnant woman to undergo OGTT at about 24 weeks of gestation. If the GDM symptoms are present after 24 weeks, the OGTT should be done again.
Slide 42-

Target Blood Glucose Values
Slide 43-

ppt slide no 43 content not found
Slide 44-

Ante-partum Management There is a consensus that once diabetes is diagnosed, the treatment should be recommended for diabetes during pregnancy. The goals of treatment are to prevent macrosomia, avoid ketosis, and detect pregnancy complications (eg, hypertension, intrauterine growth restriction, and fetal distress). The management includes diet, exercise and insulin.
Slide 45-

Diet Therapy The goals of diet therapy in GDM are to avoid ketosis, achieve normal blood glucose levels, obtain proper nutrition, and gain weight appropriately. The amount and distribution of carbohydrate should be based on clinical outcome measures (eg, hunger, blood glucose levels, weight gain), but a minimum of 175 g of carbohydrate per day should be provided. Carbohydrate should be distributed throughout the day in 5 to 7 meals and snacks. Use of a low–glycemic index diet decreases the need for insulinto maintain euglycemia.
Slide 46-

Exercise Experts recommend that women with GDM should exercise regularly to control blood glucose levels. but an improvement in clinical outcomes has not been demonstrated from compliance with this recommendation.
Slide 47-

Insulin Therapy Traditionally, insulin is used if dietary management does not maintain blood glucose at normal levels. Insulin may be initiated at 0.7 U/kg actual body weight/d given in divided dosages: two-thirds of the daily dosage before breakfast and the remainder of the dosage before dinner. Insulin therapy require close monitoring and adjustment based on blood glucose levels, meal choices, and activity levels.
Slide 48-

Obstetrics Management The goal of intra-partum GDM management is to avoid operative delivery, shoulder dystocia, birth trauma, and neonatal hypoglycemia. For patients who have maintained excellent control of blood glucose levels with diet and exercise, delivery is recommended at 40 weeks. For patients with medication-requiring GDM, induction at 38 to 39 weeks’ gestation is recommended
Slide 49-

Obstetrics management…contd In general, women with gestational diabetes who do not require insulin seldom require early delivery or other interventions. Elective cesarean delivery to avoid brachial plexus injuries in macrosomic infants is an important issue.
Slide 50-

Postpartum Management In most women with GDM, hyperglycemia rapidly resolves shortly after delivery. It is reasonable to measure a single random or fasting blood glucose level before discharge from the hospital.
Slide 51-

Postpartum Management..contd Postpartum glucose tolerance testing is important for women who had GDM. Women with GDM have a 7-fold increased risk of developing type 2 diabetes mellitus compared with those who had a normoglycemic pregnancy. At 6 to 12 weeks postpartum, only one-third of women with persistent glucose intolerance have an abnormal fasting blood glucose level. Therefore, to detect all women with glucose intolerance, a 75-g, fasting, 2-hour, oral glucose tolerance test is recommended.
Slide 52-

Summary- Key Points Universal testing of all PW for GDM Testing recommended twice in pregnancy at 1st antenatal visit and then at 24-28 weeks of gestation Single step 75 g 2 hr PPPG test to be performed PW testing positive (2 hr PPPG > 140mg/dl) should be started on MNT for 2 weeks If 2 hr PPPG ≥ 120 mg/dL after MNT, medical management (Insulin therapy) of PW to be started PW to be monitored by 2 hr PPPG throughout pregnancy
Slide 53-

Summary-Key Points..contd Antenatal visits 2 weekly in 2nd trimester & weekly in 3rd trimester PW on Insulin therapy with uncontrolled Blood glucose levels (2 hr PPPG ≥120 mg/dl) or insulin requirement >20 U/day should be referred for delivery at CEmOC centres GDM pregnancies associated with delay in lung maturity of foetus- routine delivery prior to 39 weeks not recommended. Vaginal delivery preferred, LSCS for only obstetric indications or foetal macrosomia Postpartum evaluation of glycaemic status by a 75 g OGTT at 6 weeks after delivery.
Slide 54-

Thank You